| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cinnarizine | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| cinnarizine | voltage-dependent l-type calcium channel subunit alpha-1d | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| cinnarizine | voltage-dependent l-type calcium channel subunit alpha-1f | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| cinnarizine | voltage-dependent t-type calcium channel subunit alpha-1g | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| cinnarizine | voltage-dependent t-type calcium channel subunit alpha-1h | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| cinnarizine | voltage-dependent t-type calcium channel subunit alpha-1i | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| cinnarizine | voltage-dependent l-type calcium channel subunit alpha-1s | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| cinnarizine | muscarinic acetylcholine receptor | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| cinnarizine | muscarinic acetylcholine receptor | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| cinnarizine | muscarinic acetylcholine receptor | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| cinnarizine | muscarinic acetylcholine receptor | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| cinnarizine | muscarinic acetylcholine receptor | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| cinnarizine | d(1) dopamine receptor | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| cinnarizine | dopamine d2 receptor | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| cinnarizine | d(1) dopamine receptor | small molecule | NA | drugbank | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| cinnarizine | histamine h1 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Vertigo[MeSHID:D014717] Meniere Disease[MeSHID:D008575] Disease[MeSHID:D004194] Nausea[MeSHID:D009325] Vomiting[MeSHID:D014839] Motion Sickness[MeSHID:D009041] Vestibular Labyrinth[MeSHID:D014722] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.29 | approved,investigational | antagonist |
| click here to return to the previous page | ||||||||